Nbw Capital LLC Neogenomics Inc Transaction History

Nbw Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$41.66 - $52.52 $2.15 Million - $2.71 Million	-51,582 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $1.55 Million - $2.19 Million	-42,403 Reduced 45.12%	51,582 $2.33 Million
Q1 2021 May 05, 2021	BUY	$41.56 - $59.88 $381,687 - $549,937	9,184 Added 10.83%	93,985 $4.53 Million
Q4 2020 Feb 09, 2021	SELL	$36.08 - $56.47 $1.42 Million - $2.23 Million	-39,465 Reduced 31.76%	84,801 $4.57 Million
Q3 2020 Nov 05, 2020	BUY	$33.26 - $40.48 $31,264 - $38,051	940 Added 0.76%	124,266 $4.58 Million
Q2 2020 Aug 07, 2020	BUY	$24.21 - $31.02 $2.99 Million - $3.83 Million	123,326 New	123,326 $3.82 Million

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Nbw Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Nbw Capital LLC with notifications on news.